Guardant Health
GH
#1806
Rank
HK$91.99 B
Marketcap
HK$701.37
Share price
-0.89%
Change (1 day)
106.37%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -HK$25.81

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -HK$25.92. In 2024 the company made an earnings per share (EPS) of -HK$27.88 an increase over its 2023 EPS that were of -HK$33.52.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-HK$25.81-7.42%
2024-HK$27.88-16.82%
2023-HK$33.52-33.13%
2022-HK$50.1260%
2021-HK$31.3355.04%
2020-HK$20.20207.14%
2019-HK$6.58-19.81%
2018-HK$8.20

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-HK$21.75-16.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-HK$16.76-35.35%๐Ÿ‡บ๐Ÿ‡ธ USA